What is conjecture is that somehow its NP's fault that with
What is conjecture is that somehow its NP's fault that with essentially no news the stock on low volume sees 100-200k bulk movement at one time (almost always a short attack drop) with MM's clearly controlling and manipulating the price. You can see when they release trading to occur and when it gets locked down by simply looking at the curve. Essentially not much news right now as we are waiting on trials and things to progress. Yet somehow the stock drops 2-5% per day.
Its clearly day traders, shorters and MM's making money on the churn. We can speculate and debate if it is just the OTC daily crap or an overall control of the system. Clearly cydy has been a gamed stock in the past few years.
Without any news there is no way to make money daily on a rise in price since there is nothing to justify added value to the day trader and those already tapped out to buy more. Clearly its much easier to short and dump stock and make a few pennies than to buy and hold. Everyone that could be convinced is convinced and is most likely tapped out. (i'm tapped out wishing i would have done my additional buying below 2$)
These trials progressing and working through the system takes time. They have learned so much over the past year both from a business perspective and MOA perspective. Everyone here knows this drug works. These things take years to develop and cydy is still ahead of the curve on typical development. its not going to change overnight, and thinking that new management or changing directions now will speed it up is ridiculous.
Everyone (you, me and cydy) stand to make much more on our investment staying this course.
I dont know why Yo, Patterson, etc are changing their tune except that it must make financial sense personally to them. If you recall they deemed it a moral outrage to some extend that LL was not getting EUA. Not one of them to my knowledge has said what they would do or would have done to change the current outcome.
You have CYDY on your helmet buy you wear a 13D pin. Dont you love CYDY? Are you trying to suggest something about the duality of man?
If you are on CYDY's side then how about getting with the program? Why don't you jump on the team and come on in for the big win?
12
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
You know, every time we think we're at the edge of current science, space reminds us how little we actually know. From the International Space Station up there in low Earth orbit, fresh experiments are kicking off to change what we understand about electronics cooling and drug delivery. It's a classic scenario of reaching for the stars to help us out back here on Earth....
Continue Reading
Unicycive's Legal Headache: What's Brewing? Here we go again, folks. If you're holding shares of Unicycive Therapeutics, Inc. (UNCY), buckle up because it's looking like a storm's on the horizon. The Law Offices of Howard G. Smith have dropped the news that shareholders can step up to lead a securities fraud class action lawsuit against the company. That chance to be part...
Continue Reading
A Storm Brews Over Lincoln Educational Services You know, there's nothing quite like the stink of a good mess in the markets, and Lincoln Educational Services Corporation has found itself knee-deep in one. The buzz is all about some securities fraud allegations that could rope in a bunch of investors who got the short end of the stick. It’s lawsuits like these that make...
Continue Reading
Buckle up, folks. The plastics debate is where regulatory battles and environmental concerns collide, and big changes are on the horizon. Let's talk about Bergeson & Campbell's latest shindig: "Plastics and Policy: Microplastics, EPR, and Other Emerging Trends"—a free-to-join webinar aiming to lift the lid on what's brewing beneath the surface of regulatory waters. The...
Continue Reading
Las Vegas Debuts Rise Adolescent Treatment Center Imagine being a parent in Las Vegas, staring at the daunting task of finding genuine help for your teenage kid just entering those rebellious years. The choices usually feel sparse and lacking. But on August 13, 2026, a shimmer of hope illuminated the landscape with the opening of Rise Adolescent Treatment Center. It’s a...
Continue Reading
AI-Driven Insight in Minutes: A Game Changer for B2B Hold onto your hats, because The Starr Conspiracy just lit a fire in the B2B tech world with its latest offering—Battle Card Builder. This free tool cranks out competitive intelligence in no time, literally about four minutes. Geared specifically for B2B tech marketing and sales teams, it combines decades of know-how...
Continue Reading
illycaffè Hits Milestone with B Corp™ Recertification In an era where corporate responsibility isn't just fodder for feel-good presentations, illycaffè has proven it’s not just paying lip service to the idea. The Italian coffee titan has secured its B Corp™ recertification under snazzier, sharper V2 standards. This isn't just a shiny sticker to slap on marketing...
Continue Reading
An Unplugged Move in Fleet Management There's something brewing between Motorq and Subaru that could shake up fleet operations in ways most haven't thought possible yet. We’re talking about cutting those pesky hardware cords and diving straight into a future that's software-driven—and hey, we're all here for it. Direct, Data-Driven Leadership Imagine you're a fleet...
Continue Reading
A New Era for EV Batteries in Norway Stepping into Oslo's tech realm, CATL's grand opening is not just another corporate ribbon-cutting spree. It's a big splash in Europe's battery pool, boasting the largest NING SERVICE center outside of Asia. Here we are, folks, at the crossroads where the EV market meets the nitty-gritty of practical service. Norway's Electric...
Continue Reading
Saluting the Trailblazers in Rare Disease Space Alright, let's cut to it. In a world flooded with more rare diseases than most of us can count, about 10,000 of them, only a measly 5% have any kind of approved treatment. The National Organization for Rare Disorders (NORD) is out here celebrating the folks who dare to change that bleak outlook. With the 2026 Rare Impact...
Continue Reading
Top 5 Most Recently Viewed Articles
Analyzing the Federal Reserve's Recent Actions The recent decision by the Federal Reserve to lower interest rates by 50 basis points marks a significant shift in its monetary strategy, with implications for both the U.S. economy and global markets. This rate cut reflects the Fed’s proactive approach to adapting to changing economic circumstances. KraneShares' Take on...
Continue Reading
DexCom Under Legal Investigation A class action lawsuit has emerged against DexCom, Inc. (DXCM), accusing the company of misleading investors regarding its financial performance and future growth prospects. This legal action arises from concerns that the company's management may have provided false and misleading information that ultimately hurt its investors. Details of...
Continue Reading
Financial Performance Overview Yum! Brands, Inc. (NYSE: YUM) has recently disclosed its results for the fourth quarter and full year, showcasing remarkable growth amid a challenging business landscape. The fourth-quarter earnings highlighted a GAAP EPS of $1.49 and an adjusted EPS of $1.61, marking significant progress. Comparatively, the full-year GAAP EPS reached $5.22,...
Continue Reading
Understanding Rocket Companies Inc and Its Market Dynamics Rocket Companies Inc. (NYSE: RKT) is a prominent player in the real estate market, primarily known for its innovative mortgage solutions. As market conditions evolve, investors are keen to understand how the short interest in RKT is shaping its future prospects. Current Short Interest Trends for Rocket Companies...
Continue Reading
Exciting Innovations Briefing by Zscaler for Investors Zscaler, Inc. (NASDAQ: ZS), recognized as a pioneer in cloud security solutions, is set to hold an innovations briefing designed specifically for its investors. This anticipated event will occur on June 3, during the renowned Zenith Live 2025 gathering. Details of the Innovations Briefing On June 3, 2025, starting at...
Continue Reading